French drugmaker Sanofi-Aventis is now venturing into the world of blood sugar testing, according to a recent Reuters article. The company agreed to develop monitoring systems with privately held U.S. firm AgaMatrix.
Sanofi-Aventis, makers of Lantus, an analog insulin, and Apidra, is looking to become a “healthcare” company, not just a drugmaker. The move takes the group into the world of medical devices and is part of a strategy by Chief Executive Chris Viehbacher to diversify Sanofi, reducing its traditional reliance on branded prescription drugs.
The company expects to co-develop a glucose monitoring system with AgaMatrix and begin selling the monitor in the second half of this year. AgaMatrix already makes a line of blood glucose monitoring products.
To receive free news updates from Diabetes News Hound delivered straight to your Inbox, sign up here.
If you already receive the free Alerts, spread the word by telling a friend to sign up here.
I’m not crazy about the French but maybe they have something here.